Just a little press release of sorts that I received from one of the forum members who is interested in recruiting new young doctors for research opportunities....have a look!


ASCO Conference, Atlanta, GA, USA,
June 1st through 6th, 2006.

Robert Gorter, MD, PhD, Professor of Medicine at the University of California San Francisco and Director of the Medical Center Cologne in Germany, visited the annual conference organized by the American Society for Clinical Research (ASCO) in Atlanta from June 1st through June 6th, 2006.

Dr. Gorter has been going to this ?Mecca? for oncologists since 2002. Besides that he has presented data of own studies before, one of the major reasons for Dr. Gorter to attend is to see what other colleagues are doing and to take note of new developments. Also, meeting people in between sessions and at lunch time is a very important way to do networking. Meetings like the ASCO is organizing, are attended by about 25.000 people and there are always new things. Dr. Gorter can then be very sanguinic at will, and meet several interesting people in an hour.

Dr. Gorter reported back to his colleagues at the Medical Center in Cologne and it was his strong impression that immune restoration is more and more accepted among opinion leaders in the field of Oncology. No longer is widely discussed whether immune restoration in oncologic patients makes sense and whether it is desirable; current discussions are much more concerned how to conduct proper immune restoration and how to improve efficacy of these therapies. This trend is reflected in the quickly increasing number of posters on immune restoration and the number of workshops and oral presentations.

Thus, Dr. Gorter and his colleagues, starting in 2000, have become trendsetters in the application of autologous, monocyte-derived dendritic cells, activated Natural Killer cells, and autologous stem cells.